Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-deoxy-galactopyranose
2. 6-deoxy-galactopyranoside
3. 6-deoxy-galactose
4. 6-deoxy-l-galactopyranose
5. 6-deoxy-l-galactopyranoside
6. 6-deoxy-l-galactose
7. Fuc
8. Fucose
9. L-fuc
10. L-fucopyranose
11. 87-96-7
12. L-galactomethylose
13. (3s,4r,5s,6s)-6-methyltetrahydro-2h-pyran-2,3,4,5-tetraol
14. Chebi:2181
15. (-)-fucose
16. Chembl469449
17. 6-desoxygalactose
18. (3s,4r,5s,6s)-6-methyloxane-2,3,4,5-tetrol
19. (-)-l-fucose
20. 6-deoxy-l-beta-galactose
21. Fucopyranose
22. L-galactopyranose, 6-deoxy-
23. Nsc-1219
24. 6-methyltetrahydropyran-2,3,4,5-tetraol
25. Bmse000036
26. Epitope Id:152214
27. Fucopyranose, L- (7ci)
28. Schembl63943
29. Dtxsid501016770
30. Bdbm50242419
31. L-galactopyranose, 6-deoxy- (9ci)
32. 6-deoxy-l-galactopyranosel-fucopyranose
33. C01019
34. Q409082
35. O_full_00100000000000_gs_657
36. Wurcs=2.0/1,1,0/[a1221m-1x_1-5]/1/
| Molecular Weight | 164.16 g/mol |
|---|---|
| Molecular Formula | C6H12O5 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 0 |
| Exact Mass | 164.06847348 g/mol |
| Monoisotopic Mass | 164.06847348 g/mol |
| Topological Polar Surface Area | 90.2 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 139 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
The active pharmaceutical ingredient (API) in AVTX-803 is L-fucose an oral formulation of L-fucose that enhances fucosylation of proteins in the absence of a functioning GDP-fucose transporter, partially restoring protein function.
Lead Product(s): L-Fucose
Therapeutic Area: Genetic Disease Brand Name: AVTX-803
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 02, 2022
Lead Product(s) : L-Fucose
Therapeutic Area : Genetic Disease
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The active pharmaceutical ingredient (API) in AVTX-803 is L-fucose an oral formulation of L-fucose that enhances fucosylation of proteins in the absence of a functioning GDP-fucose transporter, partially restoring protein function.
Brand Name : AVTX-803
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 02, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
10 Jan 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A L-Fucose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Fucose, including repackagers and relabelers. The FDA regulates L-Fucose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Fucose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Fucose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Fucose supplier is an individual or a company that provides L-Fucose active pharmaceutical ingredient (API) or L-Fucose finished formulations upon request. The L-Fucose suppliers may include L-Fucose API manufacturers, exporters, distributors and traders.
click here to find a list of L-Fucose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L-Fucose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Fucose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Fucose GMP manufacturer or L-Fucose GMP API supplier for your needs.
A L-Fucose CoA (Certificate of Analysis) is a formal document that attests to L-Fucose's compliance with L-Fucose specifications and serves as a tool for batch-level quality control.
L-Fucose CoA mostly includes findings from lab analyses of a specific batch. For each L-Fucose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Fucose may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Fucose EP), L-Fucose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Fucose USP).
LOOKING FOR A SUPPLIER?
Comment (5)
